---
title: "Hotgen: The business related to innovative biopharmaceuticals and early cancer screening is operated independently by a joint venture"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247307174.md"
description: "According to the announcement of Hotgen regarding stock price fluctuations, the company's current main business is the research and development, production, and sales of in vitro diagnostic reagents and supporting instruments, as well as biopharmaceuticals and related businesses such as early cancer screening, which are independently operated by the company's joint ventures ShunJing Pharmaceutical, YaoJing Gene, ZhiYuan Bio, and AoRui Bio. These related businesses are characterized by high research and development investment and high research and development risks"
datetime: "2025-07-04T11:51:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247307174.md)
  - [en](https://longbridge.com/en/news/247307174.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247307174.md)
generator: "portal-rs"
---

# Hotgen: The business related to innovative biopharmaceuticals and early cancer screening is operated independently by a joint venture

According to the announcement from Zhitong Finance APP, Hotgen (688068.SH) has released a notice regarding stock price fluctuations, stating that the company's current main business is the research and development, production, and sales of in vitro diagnostic reagents and supporting instruments, as well as biopharmaceuticals and related businesses such as early cancer screening, which are independently operated by the company's joint ventures ShunJing Pharmaceutical, YaoJing Gene, ZhiYuan Bio, and AoRui Bio. These related businesses are characterized by high research and development investment and high research and development risks

### Related Stocks

- [688068.CN](https://longbridge.com/en/quote/688068.CN.md)

## Related News & Research

- [Fuyao Glass Industry Group: Revenue up 2.44% but net profit down 17.37% on exchange losses; 65.73% payout dividend](https://longbridge.com/en/news/296203022.md)
- [How Hong Kong infrastructure, AI firms are tapping Malaysia’s growth prospects](https://longbridge.com/en/news/296165689.md)
- [11:00 ETUnderstanding Lymph System Support Supplements: PureHealth Research Highlights Natural Ingredients for Everyday Wellness](https://longbridge.com/en/news/296684348.md)
- [CanSinoBIO spotlights meningococcal vaccine strategy at Asian pediatric infectious diseases congress](https://longbridge.com/en/news/296233860.md)
- [MORNING BID AMERICAS-Bonds out, robots in](https://longbridge.com/en/news/296340709.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**